PlainRecalls
FDA Drug Moderate Class II Ongoing

Acthar Gel (repository corticotropin injection) 400 USP units/5mL (80 USP units/mL), 5mL multiple-dose vial, Rx only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1

Reported: February 28, 2024 Initiated: February 6, 2024 #D-0340-2024

Product Description

Acthar Gel (repository corticotropin injection) 400 USP units/5mL (80 USP units/mL), 5mL multiple-dose vial, Rx only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1

Reason for Recall

cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.

Details

Units Affected
8 vials involved in recall (16,479 vials distributed)
Distribution
USA nationwide
Location
Bridgewater, NJ

Frequently Asked Questions

What product was recalled?
Acthar Gel (repository corticotropin injection) 400 USP units/5mL (80 USP units/mL), 5mL multiple-dose vial, Rx only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1. Recalled by Mallinckrodt Hospital Products Inc.. Units affected: 8 vials involved in recall (16,479 vials distributed).
Why was this product recalled?
cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 28, 2024. Severity: Moderate. Recall number: D-0340-2024.